Skip to main content

Advertisement

Log in

Clinical features and long-term treatment outcomes in choroidal tuberculoma

  • Inflammatory Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To investigate the clinical features and treatment outcomes of patients with choroidal tuberculoma.

Methods

In this retrospective, observational case series, the medical records of five patients with choroidal tuberculoma who were followed up at a university hospital for at least 6 months were analyzed.

Results

Of five patients, one was male and four were female. The overall mean age was 38.0 ± 9.4 years (mean follow-up: 41.2 ± 33.8 months). Tuberculin skin test was performed in three patients, and it was positive in two of them. Interferon-gamma assay was performed in two patients and was positive in all two. Three patients had systemic tuberculosis involving the lung or other organs. Five patients were treated with antitubercular therapy for a period of 9.6 ± 8.6 months. Systemic corticosteroid treatment was performed in 3 patients, with a period of 3.5 ± 0.7 months. One patient with a recurrent vascularized tuberculoma was successfully treated with single intravitreal bevacizumab injection.

Conclusion

Choroidal tuberculoma can develop without evidence of systemic tuberculosis and can recur despite antitubercular treatment. High index of suspicion is important in early detection, and management of choroidal tuberculoma. In cases of suspected choroidal tuberculoma, positive results on immunological tests would be sufficient to initiate antitubercular therapy even if radiological evidence of systemic tuberculosis is not found. Antitubercular therapy combined with systemic corticosteroids provided favorable results. Intravitreal injection of anti-vascular endothelial growth factor may be considered for highly vascularized choroidal tuberculoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Availability of data and materials

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Code availability

None.

References

  1. Dogra M, Singh R, Agarwal A, Sharma A, Singh SR, Gautam N, Yangzes S, Samanta R, Sharma M, Aggarwal K, Sharma A, Sharma K, Bansal R, Gupta A, Gupta V (2017) Epidemiology of uveitis in a tertiary-care referral institute in North India. Ocul Immunol Inflamm 25(sup1):S46-s53. https://doi.org/10.1080/09273948.2016.1255761

    Article  PubMed  Google Scholar 

  2. Nguyen M, Siak J, Chee SP, Diem VQH (2017) The spectrum of uveitis in Southern Vietnam. Ocul Immunol Inflamm 25(sup1):S100-s106. https://doi.org/10.1080/09273948.2016.1231826

    Article  PubMed  Google Scholar 

  3. Tsirouki T, Dastiridou A, Symeonidis C, Tounakaki O, Brazitikou I, Kalogeropoulos C, Androudi S (2018) A focus on the epidemiology of uveitis. Ocul Immunol Inflamm 26(1):2–16. https://doi.org/10.1080/09273948.2016.1196713

    Article  PubMed  Google Scholar 

  4. Gupta V, Shoughy SS, Mahajan S, Khairallah M, Rosenbaum JT, Curi A, Tabbara KF (2015) Clinics of ocular tuberculosis. Ocul Immunol Inflamm 23(1):14–24. https://doi.org/10.3109/09273948.2014.986582

    Article  PubMed  Google Scholar 

  5. Annamalai R, Biswas J (2015) Bilateral choroidal tuberculoma in miliary tuberculosis - report of a case. J Ophthalmic Inflamm Infect 5:4. https://doi.org/10.1186/s12348-014-0032-x

    Article  PubMed  PubMed Central  Google Scholar 

  6. Arej N, Fadlallah A, Chelala E (2016) Choroidal tuberculoma as a presenting sign of tuberculosis. Int Med Case Rep J 9:365–368. https://doi.org/10.2147/imcrj.S119703

    Article  PubMed  PubMed Central  Google Scholar 

  7. Agrawal R, Gunasekeran DV, Agarwal A, Carreno E, Aggarwal K, Gupta B, Raje D, Murthy SI, Westcott M, Chee SP, McCluskey P, Ling HS, Teoh S, Cimino L, Biswas J, Narain S, Agarwal M, Mahendradas P, Khairallah M, Jones N, Tugal-Tutkun I, Babu K, Basu S, Lee R, Al-Dhibi H, Bodaghi B, Invernizzi A, Goldstein DA, Herbort CP, Barisani-Asenbauer T, Gonzalez-Lopez JJ, Androudi S, Bansal R, Moharana B, Mahajan S, Esposti S, Tasiopoulou A, Nadarajah S, Agarwal M, Abraham S, Vala R, Lord J, Singh R, Sharma A, Sharma K, Zierhut M, Kon OM, Kempen J, Cunningham ET, Rousselot A, Nguyen QD, Pavesio C, Gupta V (2018) The Collaborative Ocular Tuberculosis Study (COTS)-1: a multinational description of the spectrum of choroidal involvement in 245 patients with tubercular uveitis. Ocul Immunol Inflamm:1–11. https://doi.org/10.1080/09273948.2018.1489061

  8. Agarwal A, Aggarwal K, Gupta V (2019) Infectious uveitis: an Asian perspective Eye (Lond) 33(1):50–65. https://doi.org/10.1038/s41433-018-0224-y

    Article  Google Scholar 

  9. Zhang M, Zhang J, Liu Y (2012) Clinical presentations and therapeutic effect of presumed choroidal tuberculosis. Retina 32(4):805–813. https://doi.org/10.1097/IAE.0b013e3182215b5e

    Article  PubMed  Google Scholar 

  10. Tayanc E, Akova Y, Yilmaz G (2004) Indocyanine green angiography in ocular tuberculosis. Ocul Immunol Inflamm 12(4):317–322. https://doi.org/10.1080/092739490500336

    Article  PubMed  Google Scholar 

  11. Song JH, Koreishi AF, Goldstein DA (2019) Tuberculous uveitis presenting with a bullous exudative retinal detachment: a case report and systematic literature review. Ocul Immunol Inflamm 27(6):998–1009. https://doi.org/10.1080/09273948.2018.1485958

    Article  PubMed  Google Scholar 

  12. Bansal R, Beke N, Sharma A, Gupta A (2013) Intravitreal bevacizumab as an adjunct in the management of a vascular choroidal granuloma. BMJ Case Rep 2013. https://doi.org/10.1136/bcr-2013-200255

  13. Jain S, Bajgai P, Tigari B, Sharma K, Sharma A, Gupta V, Singh R (2016) Bevacizumab for paradoxical worsening treatment adjunct in HIV patient with choroidal tuberculoma. J Ophthalmic Inflamm Infect 6(1):42. https://doi.org/10.1186/s12348-016-0112-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Oehlers SH, Cronan MR, Scott NR, Thomas MI, Okuda KS, Walton EM, Beerman RW, Crosier PS, Tobin DM (2015) Interception of host angiogenic signalling limits mycobacterial growth. Nature 517(7536):612–615. https://doi.org/10.1038/nature13967

    Article  CAS  PubMed  Google Scholar 

  15. De Keyser E, De Keyser F, De Baets F (2014) Tuberculin skin test versus interferon-gamma release assays for the diagnosis of tuberculosis infection. Acta Clin Belg 69(5):358–366. https://doi.org/10.1179/2295333714y.0000000043

    Article  PubMed  Google Scholar 

  16. Haas MK, Belknap RW (2019) Diagnostic tests for latent tuberculosis infection. Clin Chest Med 40(4):829–837. https://doi.org/10.1016/j.ccm.2019.07.007

    Article  PubMed  Google Scholar 

  17. Pai M, Denkinger CM, Kik SV, Rangaka MX, Zwerling A, Oxlade O, Metcalfe JZ, Cattamanchi A, Dowdy DW, Dheda K, Banaei N (2014) Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev 27(1):3–20. https://doi.org/10.1128/cmr.00034-13

    Article  PubMed  PubMed Central  Google Scholar 

  18. Jeroudi A, Yeh S (2014) Diagnostic vitrectomy for infectious uveitis. Int Ophthalmol Clin 54(2):173–197. https://doi.org/10.1097/iio.0000000000000017

    Article  PubMed  PubMed Central  Google Scholar 

  19. Ortega-Larrocea G, Bobadilla-del-Valle M, Ponce-de-Leon A, Sifuentes-Osornio J (2003) Nested polymerase chain reaction for Mycobacterium tuberculosis DNA detection in aqueous and vitreous of patients with uveitis. Arch Med Res 34(2):116–119. https://doi.org/10.1016/s0188-4409(02)00467-8

    Article  CAS  PubMed  Google Scholar 

  20. Yeh S, Sen HN, Colyer M, Zapor M, Wroblewski K (2012) Update on ocular tuberculosis. Curr Opin Ophthalmol 23(6):551–556. https://doi.org/10.1097/ICU.0b013e328358ba01

    Article  PubMed  Google Scholar 

  21. Agarwal A, Agrawal R, Gunasekaran DV, Raje D, Gupta B, Aggarwal K, Murthy SL, Westcott M, Chee SP, McCluskey P, Ling HS, Teoh S, Cimino L, Biswas J, Narain S, Agarwal M, Mahendradas P, Khairallah M, Jones N, Tugal-Tutkun I, Babu K, Basu S, Carreno E, Lee R, Al-Dhibi H, Bodaghi B, Invernizzi A, Goldstein DA, Herbort CP, Barisani-Asenbauer T, Gonzalez-Lopez JJ, Androudi S, Bansal R, Moharana B, Mahajan S, Esposti S, Tasiopoulou A, Nadarajah S, Agarwal M, Abraham S, Vala R, Singh R, Sharma A, Sharma K, Zierhut M, Kon OM, Cunningham E, Nguyen QD, Pavesio C, Gupta V (2019) The Collaborative Ocular Tuberculosis Study (COTS)-1 Report 3: polymerase chain reaction in the diagnosis and management of tubercular uveitis: global trends. Ocul Immunol Inflamm 27(3):465–473. https://doi.org/10.1080/09273948.2017.1406529

    Article  CAS  PubMed  Google Scholar 

  22. Agrawal R, Testi I, Mahajan S, Yuen YS, Agarwal A, Kon OM, Barisani-Asenbauer T, Kempen JH, Gupta A, Jabs DA, Smith JR, Nguyen QD, Pavesio C, Gupta V (2020) Collaborative Ocular Tuberculosis Study consensus guidelines on the management of tubercular uveitis-report 1: guidelines for initiating antitubercular therapy in tubercular choroiditis. Ophthalmology. https://doi.org/10.1016/j.ophtha.2020.01.008

    Article  PubMed  Google Scholar 

  23. Gupta V, Gupta A, Sachdeva N, Arora S, Bambery P (2006) Successful management of tubercular subretinal granulomas. Ocul Immunol Inflamm 14(1):35–40. https://doi.org/10.1080/09273940500269939

    Article  PubMed  Google Scholar 

  24. Dorhoi A, Reece ST, Kaufmann SH (2011) For better or for worse: the immune response against Mycobacterium tuberculosis balances pathology and protection. Immunol Rev 240(1):235–251. https://doi.org/10.1111/j.1600-065X.2010.00994.x

    Article  CAS  PubMed  Google Scholar 

  25. Jain S, Agarwal A, Gupta V (2019) Resolution of large choroidal tuberculoma following monotherapy with intravitreal ranibizumab. Ocul Immunol Inflamm:1–4. https://doi.org/10.1080/09273948.2019.1582786

  26. Babu K, Murthy PR, Murthy KR (2010) Intravitreal bevacizumab as an adjunct in a patient with presumed vascularised choroidal tubercular granuloma. Eye (Lond) 24(2):397–399. https://doi.org/10.1038/eye.2009.83

    Article  CAS  Google Scholar 

  27. Tripathy K (2017) Choroidal neovascular membrane in intraocular tuberculosis. GMS Ophthalmol Cases 7:Doc24. https://doi.org/10.3205/oc000075

  28. Atmaca L, Yalcindag FN, Ciledag A (2012) Choroidal tuberculoma in a patient with ocular Behcet disease. Int Ophthalmol 32(1):93–96. https://doi.org/10.1007/s10792-012-9526-4

    Article  PubMed  Google Scholar 

Download references

Funding

This study was supported by a faculty research grant from Yonsei University College of Medicine [grant number 2017–32-0037]. This research was supported by the Korean Association of Retinal Degeneration.

Author information

Authors and Affiliations

Authors

Contributions

DHL, JL, and MK developed the study concept and design, as well as analyzed and interpreted the data. DHL and HC participated in data collection. DHL and MK drafted the manuscript. DHL, JL, EYC, SCL, and MK critically revised the manuscript. SCL and MK supervised the study. All the authors have read and approved the final manuscript.

Corresponding author

Correspondence to Min Kim.

Ethics declarations

Ethics approval

This study was conducted in accordance with the tenets of the Declaration of Helsinki, and was approved by the Institutional Review Board of the Gangnam Severance Hospital (IRB approval number: 3–2020-0094).

Consent to participate

The informed consent was waived.

Consent for publication

The informed consent was waived.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, D.H., Cho, H., Lee, J. et al. Clinical features and long-term treatment outcomes in choroidal tuberculoma. Graefes Arch Clin Exp Ophthalmol 260, 1641–1650 (2022). https://doi.org/10.1007/s00417-021-05474-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-021-05474-9

Keywords

Navigation